APC8015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APC8015, covering 2013-02-11 to 2013-02-11. Get the full timeline:
Most recent: Clinical Trial Update: APC8015 and Bevacizumab in Treating Patients With Prostate Cancer [Phase 2]